Skip to main content
Albion Capital Albion Capital

Main Navigation

  • Offers
  • About us
    • Albion Capital
    • Team
    • Investments
    • News and Insights
    • Albion Shareholder Magazine
    • Contact us
  • VCT Hub
    • About VCTs
    • Albion VCTs
    • Offers
    • Shareholders & IFA Information
    • AGMs & Events
    • Fraud Advice & Risk Warning
linkedin contact

Main navigation

  • Albion Capital
  • Team
  • Investments
  • News and Insights
  • Albion Shareholder Magazine
  • Contact us

Main navigation

  • About VCTs
  • Albion VCTs
  • Offers
  • Shareholders & IFA Information
  • AGMs & Events
  • Fraud Advice & Risk Warning

vct hyb

about us

Albion Capital
Albion Capital
Hp_banner_3
  
News
18th April 2022
Albion News - Spring 2022 edition
Welcome to the latest edition of our newsletter, which is available to view online or as a downloadable pdf.
Read more
  
Investment
11th April 2022
Albion news
Albion invests in RegGenome
We are pleased to announce our investment in Regulatory Genome Development Ltd (RegGenome), a commercial spin-out from the University of Cambridge.
Read more
  
Exit
4th April 2022
Albion news
MyMeds&Me announces exit to a private equity company
MyMeds&Me; a digital pharma company, has been acquired by Drug Safety and Pharmacovigilance Services Solutions (DSS)
Read more
  
Investment
31st March 2022
Albion news
AlbionVC leads a £13m Series A extension in TransFICC
Albion announces that is had led a £17 million Series A extension in TransFICC alongside existing institutional shareholders, which follows the original Series A for £7.8 million, announced in April 2020.TransFICC’s investors are AlbionV...
Read more
  
Insights
14th March 2022
Albion news
How economic events weigh on early stage investing
Sadly the Ukraine humanitarian crisis, further acceleration of inflation and an economic slowdown in Europe are certainties. How does this backdrop impact early stage investing? 
Read more
  
Insights
14th March 2022
Albion news
How economic events weigh on early stage investing
Sadly the Ukraine humanitarian crisis, further acceleration of inflation and an economic slowdown in Europe are certainties. How does this backdrop impact early stage investing? 
Read more
  
Insights
8th March 2022
Albion news
This International Women’s Day, we celebrate all the brilliant women at Albion.
We’ve asked a few volunteers to share insights about their careers, role models, lessons learnt, lack of funding to female founders and more. 
Read more
  
News
24th February 2022
Albion news
Academia raises £16m Series D to accelerate the world’s research
Academia, a platform for sharing academic research, has raised £16 million in Series D funding from Tencent and other investors.
Read more

Quick links

  • Fraud Advice & Risk Warning
  • Sustainability and ESG
  • D&I Mission Statement
  • News
  • Legal terms, privacy & cookies
  • Contact & Complaints Procedure

Albion Capital

1 Benjamin Street
Farringdon
London
EC1M 5QL

Email: info@albion.capital
Tel: 020 7601 1850

Albion Capital Group LLP is authorised and regulated by the Financial Conduct Authority

Registered in England No.
OC341254

 

We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.